Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BIO | UNICY |
|---|---|---|
| Price | $379.82 | $2.95 |
| Change today | ▲ 2.89% | ▲ 0.34% |
| Market cap | $10.16B | $10.15B |
| Return, 3 months | +29.9% | -1.7% |
| Return, year to date | +25.4% | +5.0% |
| Return, 1 year | +22.9% | -11.9% |
| P/E (TTM) | 46.3 | 24.6 |
| P/B | 1.4 | 2.0 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 2.14% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 54 | 41 |
| 30-day volatility | 29.2% | 21.1% |
| Max drawdown, 1 year | -28.9% | -22.3% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
